Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.

被引：0
|
作者：
Gogas, H [1 ]
Polyzos, A [1 ]
Tsoutsos, D [1 ]
Panagiotou, P [1 ]
Iconomou, T [1 ]
Papadopoulos, S [1 ]
Papadopoulos, O [1 ]
Agarwala, S [1 ]
Stavrinidis, I [1 ]
Fountzilas, G [1 ]
机构：
[1] HeCOG Data Off, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：723S / 723S
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer:: a phase II study by the Hellenic Cooperative Oncology Group
    Gogas, H
    Papadimitriou, C
    Kalofonos, HP
    Bafaloukos, D
    Fountzilas, G
    Tsavdaridis, D
    Anagnostopoulos, A
    Onyenadum, A
    Papakostas, P
    Economopoulos, T
    Christodoulou, C
    Kosmidis, P
    Markopoulos, C
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1737 - 1742
  • [22] Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase II study
    Fountzilas, G
    Tsavdaridis, D
    Kalogera-Fountzila, A
    Christodoulou, C
    Timotheadou, E
    Kalofonos, C
    Kosmidis, P
    Adamou, A
    Papakostas, P
    Gogas, H
    Stathopoulos, G
    Razis, E
    Bafaloukos, D
    Skarlos, D
    ANNALS OF ONCOLOGY, 2001, 12 (11) : 1545 - 1551
  • [23] Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group
    Gogas, Helen
    Pectasides, Dimitrios
    Kostopoulos, Ioannis
    Lianos, Evangelos
    Skarlos, Dimosthenis
    Papaxoinis, George
    Bobos, Mattheos
    Kalofonos, Haralabos P.
    Petraki, Kalliopi
    Pavlakis, Kitty
    Bafaloukos, Dimitrios
    Fountzilas, George
    CLINICAL BREAST CANCER, 2010, 10 (03) : 230 - 237
  • [24] Phase II trial of extended-dosing temozolomide in patients with melanoma.
    Rietschel, P.
    Ejadi, S.
    Wolchok, J.
    Krown, S.
    Gerst, S.
    Jungbluth, A. A.
    Busam, K.
    Smith, K.
    Panageas, K.
    Chapman, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 463S - 463S
  • [25] Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: A Hellenic Cooperative Oncology Group phase II study
    Papakostas P.
    Tsavdaridis D.
    Kosmidis P.
    Kalofonos H.P.
    Sakantamis A.
    Janinis D.
    Skarlos D.
    Bafaloukos D.
    Bamias A.
    Xiros N.
    Fountzilas G.
    Gastric Cancer, 2006, 9 (1) : 26 - 31
  • [26] The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: A phase II feasibility study conducted by the hellenic cooperative oncology group
    Samelis, GF
    Skarlos, D
    Bafaloukos, D
    Kosmidis, P
    Anagnostopoulos, A
    Aravantinos, G
    Dimopoulos, MA
    UROLOGY, 2003, 61 (06) : 1211 - 1215
  • [27] A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group Study
    Aravantinos, G
    Skarlos, DV
    Kosmidis, P
    Athanassiades, A
    Bafaloukos, D
    Giannakakis, T
    Karpathios, S
    Fountzilas, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 160 - 163
  • [28] Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study
    Briasoulis, E
    Kalofonos, H
    Bafaloukos, D
    Samantas, E
    Fountzilas, G
    Xiros, N
    Skarlos, D
    Christodoulou, C
    Kosmidis, F
    Pavlidis, N
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3101 - 3107
  • [29] Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: A phase II study of the Hellenic Cooperative Oncology Group
    Dimopoulos, MA
    Papadimitriou, CA
    Sarris, K
    Aravantinos, G
    Kalofonos, C
    Gika, D
    Gourgoulis, GM
    Efstathiou, E
    Skarlos, D
    Bafaloukos, D
    GYNECOLOGIC ONCOLOGY, 2002, 85 (03) : 476 - 482
  • [30] Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study
    Briasoulis, Evangelos
    Golfinopoulos, Vassilis
    Karina, Maria
    Papakostas, Pavlos
    Pavlidis, Nicholas
    Fountzilas, George
    ANTI-CANCER DRUGS, 2010, 21 (08) : 785 - 789
12345